Loomis Sayles & CO L P Xencor Inc Transaction History

Loomis Sayles & CO L P

$72.6 Billion
Q2 2024

A detailed history of Loomis Sayles & CO L P transactions in Xencor Inc stock. As of the latest transaction made, Loomis Sayles & CO L P holds 921,184 shares of XNCR stock, worth $18.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

921,184

Previous 957,811 3.82%

Holding current value

$18.7 Million

Previous $21.2 Million 17.73%

% of portfolio

0.02%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$18.21 - $24.5 $666,977 - $897,361	-36,627 Reduced 3.82%	921,184 $17.4 Million
Q1 2024 May 14, 2024	SELL	$18.65 - $26.52 $567,575 - $807,083	-30,433 Reduced 3.08%	957,811 $21.2 Million
Q4 2023 Feb 13, 2024	SELL	$16.53 - $21.42 $8.57 Million - $11.1 Million	-518,308 Reduced 34.4%	988,244 $21 Million
Q3 2023 Nov 09, 2023	SELL	$20.08 - $25.39 $8.07 Million - $10.2 Million	-401,806 Reduced 21.06%	1,506,552 $30.4 Million
Q2 2023 Aug 11, 2023	SELL	$24.77 - $29.9 $973,733 - $1.18 Million	-39,311 Reduced 2.02%	1,908,358 $47.7 Million
Q1 2023 May 11, 2023	BUY	$25.95 - $36.95 $109,457 - $155,855	4,218 Added 0.22%	1,947,669 $54.3 Million
Q4 2022 Feb 10, 2023	BUY	$24.79 - $30.86 $3.87 Million - $4.82 Million	156,098 Added 8.73%	1,943,451 $50.6 Million
Q3 2022 Nov 14, 2022	SELL	$24.62 - $32.44 $489,002 - $644,323	-19,862 Reduced 1.1%	1,787,353 $46.4 Million
Q2 2022 Aug 05, 2022	SELL	$19.74 - $29.01 $214,021 - $314,526	-10,842 Reduced 0.6%	1,807,215 $49.5 Million
Q1 2022 May 13, 2022	BUY	$26.68 - $41.63 $3.04 Million - $4.74 Million	113,818 Added 6.68%	1,818,057 $48.5 Million
Q4 2021 Feb 14, 2022	BUY	$33.67 - $43.44 $4.25 Million - $5.49 Million	126,279 Added 8.0%	1,704,239 $68.4 Million
Q3 2021 Nov 12, 2021	BUY	$30.65 - $35.68 $12.3 Million - $14.3 Million	402,062 Added 34.19%	1,577,960 $51.5 Million
Q2 2021 Aug 13, 2021	BUY	$34.33 - $44.68 $69,827 - $90,879	2,034 Added 0.17%	1,175,898 $40.6 Million
Q1 2021 May 17, 2021	BUY	$40.81 - $53.88 $2.05 Million - $2.71 Million	50,223 Added 4.47%	1,173,864 $50.5 Million
Q4 2020 Feb 12, 2021	BUY	$36.63 - $47.63 $13.1 Million - $17.1 Million	358,119 Added 46.78%	1,123,641 $49 Million
Q3 2020 Nov 12, 2020	BUY	$30.09 - $43.02 $3.72 Million - $5.31 Million	123,546 Added 19.24%	765,522 $29.7 Million
Q2 2020 Aug 14, 2020	BUY	$27.76 - $33.42 $1.55 Million - $1.87 Million	55,871 Added 9.53%	641,976 $20.8 Million
Q1 2020 May 15, 2020	BUY	$20.69 - $37.79 $74,649 - $136,346	3,608 Added 0.62%	586,105 $17.5 Million
Q4 2019 Feb 14, 2020	SELL	$32.75 - $41.43 $61,406 - $77,681	-1,875 Reduced 0.32%	582,497 $20 Million
Q3 2019 Nov 13, 2019	BUY	$33.73 - $46.27 $2.23 Million - $3.06 Million	66,237 Added 12.78%	584,372 $19.7 Million
Q2 2019 Aug 14, 2019	BUY	$29.6 - $40.93 $2.84 Million - $3.92 Million	95,810 Added 22.69%	518,135 $21.2 Million
Q1 2019 May 15, 2019	SELL	$27.85 - $38.09 $354,836 - $485,304	-12,741 Reduced 2.93%	422,325 $13.1 Million
Q4 2018 Feb 14, 2019	BUY	$32.39 - $42.05 $241,564 - $313,608	7,458 Added 1.74%	435,066 $15.7 Million
Q3 2018 Nov 13, 2018	BUY	$35.69 - $47.65 $2 Million - $2.68 Million	56,139 Added 15.11%	427,608 $16.7 Million
Q2 2018 Aug 14, 2018	BUY	$28.41 - $42.41 $10.6 Million - $15.8 Million	371,469 New	371,469 $13.7 Million

Others Institutions Holding XNCR

# of Institutions

204

Shares Held

63.1M

Call Options Held

3.9K

Put Options Held

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.21B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Account

Loomis Sayles & CO L P Xencor Inc Transaction History